Publications

• Katner, S. J., Ginsburg, E. P., Hampton, J. D., Peterson, E. J., Koblinski, J. E., & Farrell, N. P. (2023). A Comparison of Di-and Trinuclear Platinum Complexes Interacting with Glycosaminoglycans for Targeted Chemotherapy. ACS Medicinal Chemistry Letters, 14(9), 1224-1230. PMID: 37736178

• Hampton JD, Peterson EJ, et al. (2022) Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast CancerPrecision Medicine of Triplatin in Breast Cancer. Molecular Cancer Therapeutics. 21:271-81. PMID: 34815360

• Peterson, E. J., Daniel, A. G., et al. (2017). Antiangiogenic platinum through glycan targeting. Chemical Science, 8:, 241-252. PMID: 28451269.

• Silva, H., Frézard, F., Peterson, E. J., Kabolizadeh, P., Ryan, J. J., & Farrell, N. P. (2012). Heparan sulfate proteoglycan-mediated entry pathway for charged tri-platinum compounds: differential cellular accumulation mechanisms for platinum. Molecular Pharmaceutics, 9:1795-1802. PMID: 22494465

• Shoup, M., Ourahmane, A., Ginsburg, E.P., Farrell, N.P., & McVoy, M.A. (2020) Substitution-inert platinum compounds inhibit human cytomegalovirus attachment and entry. Antiviral Research. 184:104957. PMID: 33132195

• Katner, S.J., Ginsburg, E.P., Hampton, J.D., Peterson, E.J., Koblinski, J.E., & Farrell, N.P. A Comparison of Di- and Trinuclear Platinum Complexes Interacting with Glycosaminoglycans for Targeted Chemotherapy (2023). ACS. Med. Chem. Lett. (2023) 14, 1224-1230. https://doi.org/10.1021/acsmedchemlett.3c00244